Given the well‐established role of oncogenic transcription factors such as AR and ASCL1 in driving prostate cancer,[17, 23] our investigation extended to evaluating the contribution of novel lineage‐related TFs to cell growth and aggressiveness. The gene discussed is AR; the disease is Familial prostate cancer.